Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Identifying Pathogens in Ulcerative Colitis using Bioinformatics and Phenotypic-Assays

FY 2020-21

Summary
The prevalence of inflammatory bowel disease (IBD) in Canada is among the highest in the world and is estimated to affect approximately 1 in 100 Canadians by 2030. IBD can negatively impact an individual's quality of life and result in substantial costs on the health care system and society. Ulcerative colitis (UC) is a type of IBD that is characterized by inflammation of the inner lining of the large intestine. UC is thought to arise through a complex interplay of host genetics, environmental factors, the immune system, and the gut microbial community (microbiota); however, the cause of the disease remains poorly understood. There is evidence that at least in some patients, pathogenic or disease-causing bacteria may contribute to UC and the bacterial family Enterobacteriaceae are prime suspects. We hypothesize that strains of many species in the Enterobacteriaceae family, which have common virulence genes, contribute to disease activity in some patients with UC. The Surette lab is involved in randomized control trials of fecal microbiota transplantation (FMT) for adult UC and microbiome studies in early onset pediatric UC. We will use targeted culture of Enterobacteriaceae combined with metagenomic sequencing and phenotypic characterization of patient fecal samples before and after treatment. Bacterial genes and corresponding phenotypes that are important for colonization in the gut and the disruption of the gut lining will be investigated. We are particularly interested in detecting phenotypes that were lost in patients who responded to treatments and phenotypes that were constantly present in non-responder patients. Identifying an infectious role in even a subset of pediatric and adult UC patients will allow for more targeted diagnosis and treatment approaches.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449437
Name
Tertigas Dominique
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying Pathogens in Ulcerative Colitis using Bioinformatics and Phenotypic-Assays
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Enteric Pathogens; Enterobacteriaceae; Fecal Microbiota Transplantation; Inflammatory Bowel Disease; Metagenomics; Microbiome; Randomized Control Trial; Ulcerative Colitis; Virulence Genes
Abstract
The prevalence of inflammatory bowel disease (IBD) in Canada is among the highest in the world and is estimated to affect approximately 1 in 100 Canadians by 2030. IBD can negatively impact an individual's quality of life and result in substantial costs on the health care system and society. Ulcerative colitis (UC) is a type of IBD that is characterized by inflammation of the inner lining of the large intestine. UC is thought to arise through a complex interplay of host genetics, environmental factors, the immune system, and the gut microbial community (microbiota); however, the cause of the disease remains poorly understood. There is evidence that at least in some patients, pathogenic or disease-causing bacteria may contribute to UC and the bacterial family Enterobacteriaceae are prime suspects. We hypothesize that strains of many species in the Enterobacteriaceae family, which have common virulence genes, contribute to disease activity in some patients with UC. The Surette lab is involved in randomized control trials of fecal microbiota transplantation (FMT) for adult UC and microbiome studies in early onset pediatric UC. We will use targeted culture of Enterobacteriaceae combined with metagenomic sequencing and phenotypic characterization of patient fecal samples before and after treatment. Bacterial genes and corresponding phenotypes that are important for colonization in the gut and the disruption of the gut lining will be investigated. We are particularly interested in detecting phenotypes that were lost in patients who responded to treatments and phenotypes that were constantly present in non-responder patients. Identifying an infectious role in even a subset of pediatric and adult UC patients will allow for more targeted diagnosis and treatment approaches.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tertigas, Dominique
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~